TuisACUR • OTCMKTS
add
Acura Pharmaceuticals Inc
Vorige sluiting
$0,0022
Dagwisseling
$0,0023 - $0,0023
Markkapitalisasie
139,33 k USD
Gemiddelde volume
2,14 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
OTCMKTS
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | 2021info | J/J-verandering |
|---|---|---|
Inkomste | 1,56 m | -56,22% |
Bedryfskoste | 1,25 m | -33,32% |
Netto inkomste | -879,00 k | 27,24% |
Netto winsgrens | -56,24 | -66,19% |
Wins per aandeel | — | — |
EBITDA | -1,14 m | -3 360,00% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | 2021info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 65,00 k | -84,26% |
Totale bates | 860,00 k | -50,46% |
Totale aanspreeklikheid | 682,00 k | -91,06% |
Totale ekwiteit | 178,00 k | — |
Uitstaande aandele | 66,00 m | — |
Prys om te bespreek | ∞ | — |
Opbrengs op bates | -58,46% | — |
Opbrengs op kapitaal | -200,73% | — |
Kontantvloei
Netto kontantverandering
| (USD) | 2021info | J/J-verandering |
|---|---|---|
Netto inkomste | -879,00 k | 27,24% |
Kontant van bedrywe | -742,00 k | -3,20% |
Kontant van beleggings | — | — |
Kontant van finansiering | 394,00 k | 45,93% |
Netto kontantverandering | -348,00 k | 22,49% |
Beskikbare kontantvloei | -1,10 m | -238,17% |
Meer oor
Acura Pharmaceuticals Inc. is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. As of 2012, the company had several opioid products under development, which would use "Aversion Technology". As of 2014, it was a publicly traded company, listed on NASDAQ under the symbol "ACUR". Wikipedia
Gestig
1935
Hoofkwartier
Webwerf
Werknemers
9
